期刊文献+

Caveolin-3在心房纤颤组织中的表达

Expression of Caveolin-3 in atrial tissues with atrial fibrillation
下载PDF
导出
摘要 目的探讨犬心房纤颤(atrial fibrillation,AF)模型中微囊蛋白-3(Caveolin-3)蛋白表达情况。方法建立犬房颤(AF)模型,通过免疫荧光染色和Western blot技术检测心房快速起搏建立的犬AF模型及AF患者心房肌的Caveolin-3蛋白表达情况。结果在犬和人房颤的心房组织,Western blot结果显示Caveolin-3蛋白表达明显降低,与非房颤组织相比P<0.05。在犬假手术组和窦性心律的患者,免疫荧光结果显示位于心房组织细胞膜上Caveolin-3蛋白表达明显,并均匀分布在细胞膜表面;而在AF状态下,人和犬心房肌Caveolin-3蛋白表达显著降低。结论Caveolin-3参与了AF这一临床复杂病症的发生和发展。 Objective To investigate the expression of Caveolin-3 in canine model of atrial fibrillation (AF) and patients with AF. Methods Model of atrial fibrillation was estabhshed. Immunofluorescence and Western blot were used to determine the expression of Caveolin-3 in the tissues with and without AF. Results Both immunofluorescenee and Western blot showed the expression of Caveolin-3 was significantly decreased in AF tissues compared to that in the normal groups ( P 〈 0. 05 ). Immunofluoreseenee results of both canine group with sham-operation and patients with sinus rhythm showed that Caveolin-3 expressed obviously in the cell membrane of atria and distributed uniformly. However, expression of Caveolin-3 was significantly decreased in AF. Conclusion Caveolin-3 may be involved in the oceurance and development of AF.
出处 《哈尔滨医科大学学报》 CAS 北大核心 2009年第3期211-214,共4页 Journal of Harbin Medical University
基金 2006年度国家博士点基金项目(20060226019) 黑龙江省科学技术攻关重点项目(2006G2215-00)
关键词 心房纤颤 微囊蛋白-3 蛋白表达 atrial fibrillation Caveolin-3 protein expression
  • 相关文献

参考文献12

  • 1Song KS, Scherer PE, Tang Z, et al. Expression of Gaveolin-3 in skeletal, cardiac, and smoolh muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates With dystrophin and dystrophin-associated glycoproteins [ J ]. J Biol Chem, 1996,271 (25) :15160-15165.
  • 2Abi-Char J, Maguy A, Coulombe A, et al. Membrane cholesterol modulates Kvl. 5 potassium channel distribution and function in rat cardiomyecytes[ J]. J Physiol,2007,582 ( Pt 3) : 1205-1217.
  • 3Vatta M, Ackerman M J, Ye B,et al. Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome [ J ]. Circulation ,2006,114 ( 20 ) :2104-2112.
  • 4Kobayashi T, Yamada Y, Fukao M,et al. Regulation of Cavl. 2 current : interaction with intracellular molecules [ J ]. J Pharmacol Sdi, 2007,103 ( 4 ) : 347-353.
  • 5黄勤,王庭槐.心肌细胞caveolin-3的相关信号转导[J].国际病理科学与临床杂志,2005,25(4):297-299. 被引量:7
  • 6Yang BF, Shan HL, Gong DM,et al. Study on the best targets of antiarrhythmic drugs [ J ]. J Harbin Univ Commer (Nat Sei), 2002,18(1 ) :1-5.
  • 7Nattel S. New ideas about atrial fibrillation 50 years on [ J ]. Nature, 2002,415 ( 6868 ) : 219-226.
  • 8黄鑫,李莉.房颤心房肌离子通道重构的研究[J].国外医学(心血管疾病分册),2005,32(5):281-284. 被引量:5
  • 9陈林,林亚洲,陈智群,许春萱,邓玉莲,陈斌.两种不同起搏模型心房颤动发生机制的比较[J].福建医科大学学报,2005,39(4):406-409. 被引量:1
  • 10江向红,许国强.Caveolin的生物学功能及其在疾病中的作用[J].国际内科学杂志,2007,34(3):148-151. 被引量:12

二级参考文献71

  • 1Kucera JP, Kléber AG, Rohr S. Slow conduction in cardiac tissue Ⅱ: effects of branching tissue geometry[J ]. Circ Res,1998, 83: 795-805.
  • 2LiD, FarehS, LeungTK, etal. Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort[J].Circulation, 1999,100(1) :87-95.
  • 3Wu TJ, Ong JJC, Hwang C, et al. The characteristics of wave fronts during ventricular fibrillation in human hearts with dilated cardiomyopathy: role of increased fibrosis in the generation of reentry[J]. J Am Coll Cardiol, 1998, 32:187-196.
  • 4Wijffels MC, Kirchhof CJ, Dorland R, et al. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats[J]. Circulation, 1995, 92(7) :1954-1968.
  • 5Todd DM, Fynn SP, Walden AP, et al. Repetitive 4-week periods of atrial electrical remodeling promote stability of atrial fibrillation. Time course of a second factor involved in the self-perpetuation of atrial fibrillation[J]. Circulation, 2004, 109(11) :1434-1439.
  • 6Bosch RF, Seipel L, Kuhlkamp V. Remodeling in atrial fibrillation[J]. Herz, 2002,27(4) :312-321.
  • 7Dries DL, Exner DV, Gersh BJ, et al. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of left ventricular dysfunction[J]. J Am Coll Cardiol, 1998, 32(3): 695-703.
  • 8Wang TJ, Larson MG, Levy D, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham heart study[ J ]. Circulation,2003,107(23): 2920-2925.
  • 9Moe GK, Abildskov JA. Atrial fibrillation as a self-sustaining arrhythmia independent of focal discharge[J]. J Am Heart, 1959,58(1):59-70.
  • 10Nitta T, Imura H, Bessho R, et al. Wavelength and conduction in homogeneity in each atrium in patients with isolated mitral valve disease and atrial fibrillation [ J ]. J Cardiovasc Electrophysiol, 1999,10(4) :521-528.

共引文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部